Myrotx

1 known investors

Myrobalan Therapeutics develops oral small molecule therapies targeting demyelination and neuroinflammation in central nervous system diseases such as multiple sclerosis, Alzheimer's, ALS, and Parkinson's. The company uses biomarker-guided precision neurology to identify brain-penetrant compounds for CNS drug discovery.